IIPLA News
Monday, June 15, 2026

USPTO Director Issues Informative Decision Denying Discretionary Institution Denial in Tesla IPR Case

Director cites vacated trial date, petitioner’s stipulation, apparent Office error, early patent challenge, and U.S. manufacturing evidence as factors against denying institution

IIPLA News Deskanonymous access0 articles left this week
USPTO Director Issues Informative Decision Denying Discretionary Institution Denial in Tesla IPR Case

The United States Patent and Trademark Office (USPTO) Director issued an informative decision on June 15, 2026, in the matter of Tesla, Inc. v. Bulletproof Property Management, LLC (IPR2026-00204), addressing the question of whether to discretionarily deny institution of inter partes review (IPR).

In this decision, the Director declined to exercise discretion to deny institution despite multiple considerations that sometimes weigh in favor of denial. The decision was published as Paper 14 and is designated as informative, providing guidance on the application of the Office’s memorandum regarding discretionary denial.

Key factors influencing the Director’s decision included the procedural posture of the related district court litigation. Specifically, the trial date in the co-pending parallel district court case had been vacated. This procedural development, combined with the petitioner’s submission of a broad stipulation, allowed the IPR proceeding to function effectively as an alternative forum to the district court litigation.

Additionally, the petitioner demonstrated what the Director described as an apparent Office error. This factor supported allowing the IPR to proceed to address the patentability issues raised.

The timing of the petitioner’s challenge also weighed in favor of institution. The petitioner brought the challenge at an early stage, which the Director noted as a positive consideration under the discretionary denial framework.

Importantly, the petitioner provided evidence of U.S. manufacturing specific to the accused products. The Director recognized this as a significant factor weighing against discretionary denial, reflecting the USPTO’s consideration of the impact on domestic manufacturing in its discretionary decisions.

Taken together, these multiple considerations led the Director to decline to deny institution discretionarily, allowing the IPR to proceed. The decision underscores the USPTO’s nuanced approach to discretionary denial, balancing procedural, substantive, and policy factors.

This informative decision serves as a reference point for future cases where discretionary denial is contemplated, particularly where parallel litigation is involved and evidence of U.S. manufacturing is presented.

Share This Article
Ready-to-post copy includes the article link.

USPTO Director Issues Informative Decision Denying Discretionary Institution Denial in Tesla IPR Case In a June 15, 2026 informative decision, the USPTO Director declined to exercise discretion to deny institution of inter partes review in Tesla, Inc. v. Bulletproof Property Management, LLC. The decision highlights mult... Read the full IIPLA article: https://iipla.org/news/uspto-director-issues-informative-decision-denying-discretionary-institution-denial-in-tesla-ipr-case

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsMiddle East

Anthropic Alleges Alibaba Conducted Extensive AI Model Extraction Operation

Anthropic, a US-based artificial intelligence company, has accused Chinese tech giant Alibaba of orchestrating a massive campaign to extract capabilities from its Claude AI model. The operation, described as a 'distillation' effort, involved nearly 25,000 fraudulent accounts generating over 28.8 million interactions b…

Thursday, June 25, 2026
PatentsMiddle East

Traditional Chinese Supplements Market Projected to Expand at 6.8% CAGR

The Traditional Chinese Supplements market is experiencing steady growth, with a compound annual growth rate (CAGR) of 6.8%. This expansion reflects increasing consumer interest and demand for traditional herbal health products. Market.us provides detailed analysis highlighting the market size and growth prospects.

Thursday, June 25, 2026